Studies were initiated to investigate the effects of hypoxia on the conversion of angiotensin I (AI) to angiotensin II (All) in microvessels of the lung. Using the technique of allografting neonatal lung tissue into the cheek pouch of normal hamsters, the microvessels of the lung, pulmonary arterioles, and venules could be visualized and manipulated by direct in vivo microscopy. The microvessels of the lung were studied 7-10 days after allografting by anesthetizing the hamster with pentobarbital (6.0 mg/ 100 g body weight i.p.) and then preparing the lung tissue for observation. The tissue was suffused with a Ringer's bicarbonate solution bubbled with a normal (20% O 2 -5% CO 2 -75% NJ or a low (95% N 2 -5% COj) oxygen mixture. After equilibration, a pulmonary arteriole or venule was selected for observation, and the vessel geometry was recorded. Then, a micropipette containing either AI or All was positioned alongside the vessel, and the agent was delivered continuously for 2 minutes. Lumen diameter was recorded continually for 8-10 minutes. This procedure was repeated until both angiotensins were tested on pulmonary arterioles and venules under conditions of a normal and low oxygen environment. This protocol was repeated on cheek pouch microvessels that did not contain pulmonary allografts. Both AI and All produced rapid decreases in the lumen diameters of all microvessels tested. This vasoconstriction was greater for All, and the oxygen environment did not alter the response. Conversion of AI to AH was not altered by the oxygen environment, and the relative conversion was similar in the microvessels of the lung and cheek pouch. These studies demonstrated that acute hypoxia does not alter the conversion of angiotensin in either pulmonary or cheek pouch microvessels. Thus, an altered enzymatic activity may be restricted by the endothelial cell surface area available for conversion of angiotensin. 2 on the primary role of the pulmonary circulation in the conversion of angiotensin I (AI) to angiotensin (All) stimulated early interest in the subcellular location and properties of angiotensin converting enzyme (ACE). Ryan et al, 3 using antibodies to locate the enzyme immunohistochemically, placed the enzyme clearly on the luminal surface of the endothelial cells that line the vasculature. Ng and Vane, 1 Aiken and Vane, 4 and others 3 5 have reported that the endothelium of the lungs is the major site for conversion of AI to All, primarily because of the large surface area of the endothelium in the lung that would be available for the converting enzyme and the position of the lung as it relates to vascular volume and blood flow in the circulatory system.
T he observations of Ng and Vane'
2 on the primary role of the pulmonary circulation in the conversion of angiotensin I (AI) to angiotensin (All) stimulated early interest in the subcellular location and properties of angiotensin converting enzyme (ACE). Ryan et al, 3 using antibodies to locate the enzyme immunohistochemically, placed the enzyme clearly on the luminal surface of the endothelial cells that line the vasculature. Ng and Vane, 1 Aiken and Vane, 4 and others 3 5 have reported that the endothelium of the lungs is the major site for conversion of AI to All, primarily because of the large surface area of the endothelium in the lung that would be available for the converting enzyme and the position of the lung as it relates to vascular volume and blood flow in the circulatory system.
More recently, investigators have been studying the effects of hypoxia in the pulmonary circulation on the activity of converting enzyme. Catravas and Gillis 6 used an enzyme-specific substrate, 3 H-benzoyl-pheala-pro ([ 3 H]BPAP), to make direct measurements of ACE activity with hypoxia in the pulmonary circulation as well as measurements of pulmonary blood flow and mean transit time of [ 3 H]BPAP through the pulmonary circulation. Their conclusion was that alterations in pulmonary hemodynamics were the primary results of hypoxia and that in physiologic states, the decrease in ACE activity was secondary to, or a direct result of, these hemodynamic alterations.
Szidon et aJ 7 also found a decrease in converting enzyme activity during hypoxia in the lung, in situ. They believed that the decreased converting activity was a result of a decrease in converting enzyme activity. However, in a subsequent study, Szidon et al 8 reported that hypoxia does not alter the converting enzyme activity of cultured pulmonary endothelial cells, and the same laboratory 9 reported that hypoxia does not alter the converting enzyme activity of the isolated perfused rat lung. These two studies led the authors to suggest that the hypoxia-induced decrease in converting enzyme activity in the intact in situ lung was probably the result of hemodynamic changes induced by hypoxia.
To determine whether hypoxia directly effects the activity of ACE, techniques developed by this laboratory 10 -' 3 were employed to make direct measurements of ACE activity of microvessels in pulmonary and hamster cheek pouch tissue in normal and hypoxic conditions. In addition, the activity of ACE in arterioles and venules were determined and compared using these tissues.
Materials and Methods

Preparation of Pulmonary Allograft
Pulmonary tissue harvested from fetal hamsters, 14-16 days gestation, was transplanted into the cheek pouch of golden hamsters {Mesocricetus auratas) (SASCO, Inc., Omaha, Neb.) according to the techniques described by Davis et al" as modified from that of Click et al. 10 Female hamsters weighing 100-150 g were used as recipients for the pulmonary allografts. Fetal hamsters were removed by cesarean section, and the lower lobe of the left lung was prepared for allografting by sectioning into small (1 mm 2 ) pieces. The left cheek pouch of an adult hamster anesthetized by pentobarbital sodium (6.0 mg/100 g body wt i.p.) was prepared for allografting by inserting a small baseplate into the cheek pouch and exposing the underlying cheek pouch membrane via an incision in the skin and its retraction around the baseplate. Then, a thin layer of avascular tissue was removed from the cheek pouch membrane, and 2 or 3 pieces of pulmonary tissue were placed on the cheek pouch membrane. A saran-covered upper chamber was seated over the pulmonary tissue, cheek pouch membrane, and baseplate. The skin was brought into apposition around this upper chamber and was sutured and/or glued into place around the rim of the upper chamber. The well in the upper chamber was filled with gauze and taped. Each hamster was given an injection of Wycillin (6.000 U/100 g/d s.q.) on the day of allografting and every day for the next 5 days. Hamsters recovered on a warm heating pad and were returned to their hanging cages. Food and water were given ad libitum.
Observation and Recording for Pulmonary Allografts
Eight to fourteen days following allografting when the pulmonary tissue had a well-developed vasculature, 12 the hamsters were anesthetized with pentobarbital sodium, as described above. The tape and gauze plug were removed, the hamster was placed on a heated, movable microscope stage, the upperchamber was clamped to the stage, and the well was suffused with a Ringer's bicarbonate-buffered solution.
i: The saran covering was removed carefully, exposing the underlying pulmonary tissue and cheek pouch membrane. The allograft and cheek pouch membrane were transilluminated by placing a fiberoptic bundle with a beveled (45° angle) tip into the cheek pouch of the hamster. The mirror was positioned under the cheek pouch and light was supplied by a Zeiss 100-watt mercury bulb. The optical system incorporated a Zeiss microscope (Collins Microscope Co., Kansas City, Kan.) with a Leitz 10 X objective. The image was projected through an image-rotator (I x ) into a closed-circuit television system consisting of a 4100 Cohu camera, a Conrac monitor, and a JVC CR-60604 videocassette recorder. Vascular diameters in control and in activated states were measured on the monitor with a Colorado Video Inc. Model 305 video micrometer (Denver, Colo.). This video micrometer was calibrated routinely with a Zeiss micrometer, and the measurements were found to have less than I % error. Diameter measurements, suffusate temperature, Po 2 of the sulfate, and blood pressure were recorded on a Grass Model 59 multichannel recorder (Grass Instrument Co., Quincy, Mass.) for later analysis.
Observation and Recording From Microvessels of the Cheek Pouch
For these experiments, an upper and lower chamber were inserted into the cheek pouch of an adult female hamster just prior to experimentation. This acute preparation was done in a manner similar to that used for transplantation with the exception that 1) no fetal tissue was placed on the membrane, 2) more of the connective tissue was removed, and 3) the upper portion of the chamber had no saran covering.
Measurements of Oxygen Content in Suffusion Fluids
The pulmonary tissue and cheek pouch vasculature were suffused from a reservoir at 4-5 ml/min with a Ringer's bicarbonate solution that was heated (36-37° C) and bubbled with a gas mixture that contained either normal oxygen (20% 0,-5% CO,-75% N,) or low oxygen (5% CO,-95% N,) with venting to drive off gas over the fluid in the reservoir. The pH of the solution with either gas mixture was maintained at 7.5 ± 0 . 1 , and the Pco, was 30-40 mm Hg. Pco,, Po, and pH were measured with an IL813 blood-gas analyzer (Instrumentation Laboratories, Houston, Tex.). Fluid samples were drawn in glass syringes from the suffusate reservoir, the suffusion line, and the chamber well. As we were interested in performing some of the experiments with a low oxygen environment, the suffusate Po, was monitored with a Clarktype electrode placed in the suffusion reservoir. 1415 This electrode was coupled to a multichannel recorder so that a continuous recording of suffusate Po, was made. The electrode was calibrated by bubbling the suffusate with a normal oxygen mixture describing the maximum concentration as a full scale deflection above midline; bubbling with the low oxygen mixture described the minimal oxygen concentration as giving full scale deflection below midline. These settings were confirmed routinely by sampling the reservoir and chamber fluid, as described earl ier. With a normal oxygen mixture bubbl ing the suffusate, the mean Po, of the fluid was 145.2 ±2.2 mm Hg (n = 26), and with a low oxygen mixture bubbling the suffusate, the mean Po,ofthe fluid was 16.9 ± 1.4mm Hg (n = 46). The variation of Po, measurements in fluid drawn from either the reservoir or the chamber well was small; the Po, of the chamber was consistently 1-2 mm Hg higher than the Po, of the reservoir, indicating that there had been contamination of the hypoxic environment.
Application of Agents to Selected Microvessels
Micropipettes were manufactured with a conventional, vertical pipette puller (model 708C, David Kopf Instruments, Tujunga, Calif.), and the tips were beveled to a diameter of 16-20 /um using a motor-driven wheel (World Precision Instruments, Inc., New Haven, Conn.) coated with abrasive paper.
To apply test solutions to microvessels, the pipettes were attached to a Leitz micromanipulator via a two-way holder. One end of the holder was connected to the pipette while the other end was connected to a microdrive pump (Stoelting Co., Chicago, 111.). Each test solution was applied at a constant rate of 10 ^il/min, and the application system was calibrated regularly via timed collections and weighing. After a vessel was selected for study, the tip of the micropipette was positioned perpendicular to the vessel about 1-2 pirn away from the outside edge of the vessel (Figure 1) . Measurements of the internal diameter of the vessel were made before and after positioning the pipette. Then, the test solution was administered at a constant rate for 2 minutes while the diameter of the vessel was measured continuously. The application was stopped, the pipette was raised out of the suffusion solution, and the diameter of the vessel was measured continuously for another minute. The vessel diameter was measured once every minute for the next 4 minutes.
Using the microdrive pump, we were able to apply a constant volume of the angiotensin solutions (angiotensin I and II, Isoleucine, Sigma Chemical Co., St. Louis, Mo.) at a rate of 10 /ttl/min to a specific site on a microvessel. Thus, since all of the applications of angiotensin lasted for 2 minutes with a total volume of 20 fi\ applied, the angiotensin delivery was expressed as the total amount (ng) of angiotensin given during the 2-minute interval. The final solutions of angiotensin were prepared fresh each week from stock solutions that were kept frozen.
Experiment Design
The effect of hypoxia on the response of pulmonary arterioles and venules to angiotensin I (AI) and angiotensin II (All) is described below.
In the first design, the pulmonary tissue was exposed to either a normal or low oxygen environment. In 14 hamsters, the Po 2 of the suffusion solution was maintained at normal values throughout the experiment, while in another group of 4 hamsters, the pulmonary tissue was exposed to a low oxygen environment throughout the experiment. In both types of experiments, the pulmonary tissue was allowed to equilibrate with the suffusion solution for lOminutes. A pulmonary arteriole and venule (10-40 /urn) were selected for study. Then, either AI or All was microapplied to one of the pulmonary arterioles, as described previously; this procedure was repeated on the pulmonary venule. Arterioles and venules were distinguished by the direction of red cell flow and vessel divergence (arterioles) or convergence (venules). Then, the other angiotensin was applied to the same pulmonary vessels in a similar manner. The vascular responses were recorded for analysis later. In some experiments, another pulmonary arteriole or venule would be selected, and the procedure repeated.
In the second design, pulmonary tissue in 9 hamsters was initially exposed to either a normal or a low oxygen environment. Then, the tissue was exposed to the other oxygen environment. Thus, the vascular responses to AI and AH were measured in the same pulmonary arterioles and venules under conditions of both normal and low oxygen environments. At the beginning of each experiment, the suffusion solution was bubbled with either normal or low oxygen gas mixture, and the tissue was allowed to equilibrate (10 minutes) after suffusion began. The applications of Al and All were random with applications of both drugs being made to both arterioles and venules (20-40 /urn). Then, the gas bubbling the reservoir was switched so that the gas with the opposite Po 2 value was bubbling the reservoir. The reservoir, suffusion system, and tissue were allowed 10-15 minutes to equilibrate to the new Po 2 level. Then, applications of Al and All to the same pulmonary arteriole and venule were repeated. Before, during, and after the alteration of the suffusate Po 2 , the luminal diameter of the arteriole and venule was measured at 5-minute intervals; thus, any changes in luminal diameter because of a change in the oxygen environment surrounding the vessel were documented. All of these vascular measurements were recorded for later analysis. The effect of hypoxia on the response of cheek pouch arterioles and venules to Al and All is described below. In 8 hamsters, acute preparations of the cheek pouch were completed using a removable chamber; in 4 of these hamsters, the cheek pouch was exposed to a normal oxygen environment while in the other 4 hamsters, the environment was the low oxygen mixture. In both groups of hamsters, a cheek pouch arteriole and venule (20-40 /xm) were selected. The architecture and topography of these vessels were recorded and, because of the tachyphylactic nature of angiotensin, different sites along each vessel were tested by microapplication of either Al or All. Both agents, selected randomly, were tested on an arteriole and venule as described previously.
In the other protocol, cheek pouch vessels in 8 hamsters were exposed to both a normal and low oxygen environment, and therefore each animal served as its own control. The initial Po 2 of the suffusion solution was set randomly at either normal or low oxygen values, and the effect of Al or All was determined as described previously. Then, the gas mixture was switched so that the other gas mixture was bubbling the suffusion solution. The reservoir, suffusion system, and tissue were allowed 10-15 minutes to equilibrate to the new oxygen environment. Then, applications of Al and All were completed again. All data were recorded for analysis later.
Data Analysis
The vascular response was calculated as the percent change in vascular diameter from the control state to the activated state (%A D c ).
The activity of angiotensin converting enzyme (ACE) was defined as the percent conversion of Al to All. The percent conversion of Al to All was calculated using the formula of Gerlings and Gilmore 16 :
(%A D c for AI/%A D c for All) x 125 = % conversion for AI+AII where the percent change in diameter (%A D c ) was defined as the minimum diameter of the lumen (maximum constriction) subtracted from the diameter of the lumen in the control state (control diameter) divided by the control diameter and multiplied by the constant 125, which is the ratio of the molecular weights of AI:AII multiplied by 100. Using the analysis of variance (ANOVA), followed by the Neuman-Keuls test, comparisons were made of ACE activity with normal and low oxygen environments, of the pulmonary and cheek pouch responses to Al and All, and of the percents of conversion of these different vessels and of control diameter measurements of both pulmonary and cheek pouch microvessels with normal and low oxygen environments." In some cases, both paired and unpaired Student's t tests were used to determine significant differences. 17 The level of significance for all tests was set at/?<0.05.
Results
Pulmonary microvessels exhibited a characteristic response to both Al and AH. When angiotensin was applied to either the pulmonary arteriole or venule (Figure 1 ), there was a rapid decrease in luminal diameter to a minimum diameter, or maximal constriction, within 30-60 seconds, and as the application continued for 2 minutes, luminal diameter remained at a plateau for the remainder of the application. With termination of the application of angiotensin, the vessel returned rapidly to control values. The average diameter of the vessel during the plateau phase of the response was taken as the activated state or maximum constrictor response. The cheek pouch microvessels also exhibited a rapid decrease in diameter with the application of angiotensin (Figure 1) . A minimum diameter, or maximal constriction, was reached within 30-60 seconds, but once this point was reached, the vessel gradually dilated toward control value. This minimum diameter, or maximal constriction, was used as the value in calculating the response of the vessel. The vasoconstrictor effect of angiotensin II appeared greater than the effect of Al on all of the microvessels studied. Also, these responses did not appear to be altered by a low oxygen environment.
In the control state, i.e., before either Al or All were applied and after equilibration with the suffusion fluid, the lumen diameter of all microvessels was measured ( Figure 1 and Table 1 ). Pulmonary arterioles and venules exhibited a significant vasoconstriction with the low oxygen environment while there was very little change in the diameter of microvessels in the cheek pouch after changing the oxygen environment.
When both Al and All were tested on pulmonary or cheek pouch microvessels with normal and/or low oxygen in the suffusing fluid, the response (% change in the lumen diameter) of the microvessels to All was significantly greater than that for Al (Tables 2 and 3) . Altering the oxygen environment produced no significant effect on the response of pulmonary arterioles, pulmonary venules, or cheek pouch venules to Al or All. In the protocol in which each cheek pouch arteriole was exposed to either a low or high Po 2 (unpaired comparison), hypoxia did not alter the response of the vessels to angiotensin (Table 2 ). However, in the protocol in which each vessel was exposed to both a low and high Po,, the low Po, environment significantly attenuated the vasoconstrictor effect of both angiotensins but not the percent conversion (Table 3) . Thus, the conversion of AI to All by any of these microvessels was not effected significantly by the low oxygen environment (Figure 2 and Tables 2 and 3 ). This is shown graphically for each microvessel in Figure 2 .
When comparisons were made between the various microvessels using analysis of variance followed by Newman-Keuls posthoc test for ordered differences for any given oxygen environment, the response of the microvessels to Alor All, specifically, i.e., the %AD C , the response of the cheek pouch arteriole was significantly greater than that of the pulmonary arteriole or cheek pouch venule, and responses of these latter microvessels were significantly greater than those of the pulmonary venule, i.e., CPA>PA = CPV>PV. However, for the conversion of AI to All, there were no significant differences between any of the microvessels, i.e., CPA = PA = PV = CPV.
Discussion
The development of the technique for transplanting pulmonary tissue into the hamster cheek pouch provides a unique model that allows in vivo observation of the responses of pulmonary microvessels to various environments and the microapplication of vasoactive agents. Histologic studies by Davis et al" have shown that the transplanted pulmonary tissue contains all of the cell types present in normal fetal lung tissue. The microvessels that develop in the allograft also have responses differing from those of the cheek pouch microvessels. The pulmonary microvessels do not exhibit tachyphylaxis to angiotensin as do the cheek pouch microvessels. A number of investigators' 8 " 20 have reported tachyphylaxis of systemic vessels to repeated applications of angiotensin. Moore and Khairallarr' noted that although most of the many tissues responsive to angiotensin are tachyphylactic, one of the few exceptions is pulmonary tissue. Thus, the pulmonary allograft has morphologic and physiologic characteristics similar to normal in situ vessels of the lung. Pulmonary microvessels responded to changes in the oxygen content of the suffusate (Table 1) so that when the Po, of the suffusate was lowered, the pulmonary vessels exhibited a significant degree of vasoconstriction, a response that is consistent with the reports of many investigators for hypoxia in the lungs. We observed a pulmonary arteriole vasoconstriction to hypoxia of 16%, a change consistent with reports of Davis et al 12 -" (19%) and Kato and Staub (18%) . 22 In the present study, a significant pulmonary venoconstriction in response to hypoxia was also observed. We have no explanation for our failure to observe hypoxic venoconstriction in our previous study. 13 Rivera Estrada et al" and Morgan et al 24 also have reported venoconstriction to hypoxia, although in these latter studies, the venules tested were of a larger diameter than the venules we measured. It has been postulated that the vasoconstrictor response of arterioles to hypoxia may be a protective mechanism of the lung to direct blood flow to patent alveoli and so provide the best ventilation perfusion ratio for gas exchange. The venoconstriction to hypoxia that we are reporting may have some role in maintaining or balancing hydrostatic pressure in the capillary system so that when hypoxia induces arteriolar constriction, capillary hydrostatic pressure may be buffered, thereby mitigating the increase in fluid and solute exchange between capillaries, the alveolar interstitium, and pulmonary lymphatics.
The conversion of AI to All with normoxia was approximately 95% in all of the vessels that were tested. This amount of conversion is consistent with the reports of pulmonary angiotensin converting enzyme (ACE) activity by Catravas and Gillis. 6 comparing the ACE activity of pulmonary vs. cheek pouch arterioles with either normal or low oxygen conditions, there appears to be no difference in the ACE activity of any of these microvessels. These first measurements of the percent conversion of angiotensin by pulmonary and systemic microvessels in vivo would seem to confirm the hypothesis of Ryan et al 3 and Cushman and Cheung 5 that ACE is distributed homogenously throughout the vascular system and that the activity of ACE is uniformly high. We also found that the venular ACE activity was equal to that of the arteriolar ACE activity in both pulmonary and cheek pouch microvessels under both normal and hypoxic conditions. This is further evidence for the homogenous distribution and activity of ACE.
Comparisons of the percent conversion of AI to All in a normoxic or hypoxic environment showed that the activity of ACE was not inhibited or altered by the hypoxic environment. This was true for both the pulmonary and cheek pouch microvessels. The activity of ACE is determined by delivery of substrate to the enzyme and the amount of ACE available (i.e., vascular endothelial surface area) for conversion activity. 6 In the normal lung, hypoxia generally alters the delivery of substrate, blood flow, and surface area available for conversion activity. In our experiments, AI or All was applied directly on the vessels and therefore did not depend on blood flow through the small pulmonary arteriole. Hypoxic vasoconstriction may have reduced the vascular endothelial surface and, thus, the amount of ACE available. However, this should have decreased ACE activity, a response that was not observed.
One concern was that the oxygen level of the vascular endothelium was not as low (10-20 mm Hg) as we had measured. Jackson and Duling 26 have shown that because of the high oxygen capacity of blood and the permeability of the vascular wall to oxygen, a large reduction in suffusate Po 2 does not necessarily imply an equivalently large reduction in Po 2 of the perivascular region and/or intravascular Po 2 . However, the appropriate response of the pulmonary microvasculature to the low oxygen environment indicated that the Po 2 had been altered and reduced to a degree that caused vasoconstriction of the pulmonary arterioles and venules. However, no change in the activity of ACE was found. Therefore, we believe that although the absolute value of the Po 2 that we report may be debated, the fact that a significant and appropriate shift in pulmonary vascular diameter in response to lowering the level of oxygen was found with no concomitant change in the activity of ACE is consistent with the conclusion of Catravas and Gillis, 6 i.e., hypoxia that induces a physiologic change in pulmonary hemodynamics does not alter the angiotensin enzyme activity of the cells in pulmonary arterioles and venules. Thus, the effect of hypoxia on the conversion of angiotensin I probably is because of alterations of the surface area available for the interaction of the enzyme (ACE) with the substrate, which in this case is angiotensin I.
Our conclusions from these experiments are that: 1) the pulmonary microvasculature responds to hypoxia with a significant vasoconstriction, 2) the percent conversion of Alto All is not different in arterioles and venules, and the pulmonary and cheek pouch microvessels exhibit similar capacities for the conversion of AI to All, and 3) the percent conversion of AI to All, which is one of the activities of ACE, is not altered by hypoxia.
